Canada markets close in 12 minutes

Provectus Biopharmaceuticals, Inc. (PXY.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.04500.0000 (0.00%)
As of 02:55PM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
1,749
1,749
2,389
2,608
2,813
Selling General and Administrative
1,732
1,732
2,025
2,055
2,145
Total Operating Expenses
2,910
2,910
3,391
4,636
4,932
Operating Income or Loss
-2,910
-2,910
-3,391
-4,636
-4,932
Interest Expense
216.214
216.214
163.691
961.698
1,748
Total Other Income/Expenses Net
24.227
24.227
0.433
58.174
-1.273
Income Before Tax
-3,102
-3,102
-3,555
-5,540
-6,678
Income from Continuing Operations
-3,102
-3,102
-3,555
-5,540
-6,678
Net Income
-3,102
-3,102
-3,555
-5,540
-6,678
Net Income available to common shareholders
-3,102
-3,102
-3,555
-5,540
-6,678
Basic EPS
-0.01
-0.01
-0.01
-0.01
-0.02
Diluted EPS
-0.01
-0.01
-0.01
-0.01
-0.02
Basic Average Shares
419,502
419,508
419,470
408,223
393,252
Diluted Average Shares
419,502
419,508
419,470
408,223
393,252